Related Experiment Videos
Invasive versus non-invasive testing in red-cell alloimmunized pregnancies
1Mt. Sinai Hospital, Fetal Assessment Unit, 600 University Avenue, Ont., M5G 1X5, Toronto, Canada. doepkes@hotmail.com
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|September 15, 2000
Summary
Amniotic fluid bilirubin tests for fetal anemia in red-cell alloimmunization may be unreliable. Non-invasive Doppler ultrasound shows promise for predicting fetal hemolytic anemia, potentially replacing amniocentesis.
Area of Science:
- Maternal-Fetal Medicine
- Diagnostic Imaging
- Hematology
Background:
- Red-cell alloimmunization poses risks to fetal health.
- Amniocentesis for bilirubin levels is a traditional method for assessing fetal disease severity.
- Concerns exist regarding the reliability of amniotic fluid bilirubin measurements.
Purpose of the Study:
- To review the effectiveness of amniocentesis, ultrasonography, and Doppler in predicting fetal hemolytic anemia.
- To evaluate current diagnostic strategies for red-cell alloimmunization.
Main Methods:
- Literature review of studies on amniocentesis, ultrasonography, and Doppler for fetal anemia prediction.
- Analysis of evidence regarding the accuracy and limitations of each method.
Main Results:
- Amniotic fluid bilirubin measurements have limited value, especially in the second trimester.
- Ultrasound and Doppler parameters, particularly umbilical venous and middle cerebral artery flow velocities, show promise.
- Existing prospective studies have design limitations or insufficient data.
Conclusions:
- Non-invasive Doppler assessments may offer sufficient accuracy for clinical management.
- These methods could potentially replace amniocentesis in predicting fetal hemolytic anemia.
- Further well-designed prospective studies are required to validate these non-invasive techniques.